Literature DB >> 10945038

Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia.

M C Le Bousse-Kerdilès1, M C Martyré.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10945038     DOI： 10.1007/bf00870307

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  123 in total

1.  Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors.

Authors:  L Lagneaux; A Delforge; D Bron; M Massy; M Bernier; P Stryckmans
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

Review 2.  Malignant disorders of megakaryocytes.

Authors:  L D Cripe; R Hromas
Journal:  Semin Hematol       Date:  1998-07       Impact factor: 3.851

3.  Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis.

Authors:  Z C Han; J Briere; G Nedellec; J F Abgrall; L Sensebe; D Parent; G Guern
Journal:  Eur J Haematol       Date:  1988-02       Impact factor: 2.997

4.  Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor.

Authors:  L J Oliver; D B Rifkin; J Gabrilove; M J Hannocks; E L Wilson
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

5.  Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.

Authors:  B Dupriez; P Morel; J L Demory; J L Lai; M Simon; I Plantier; F Bauters
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

6.  Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia.

Authors:  M C Le Bousse-Kerdilès; S Chevillard; A Charpentier; N Romquin; D Clay; F Smadja-Joffe; V Praloran; B Dupriez; J L Demory; C Jasmin; M C Martyré
Journal:  Blood       Date:  1996-12-15       Impact factor: 22.113

7.  Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders.

Authors:  H Castro-Malaspina; R E Gay; S C Jhanwar; J A Hamilton; D R Chiarieri; P A Meyers; S Gay; M A Moore
Journal:  Blood       Date:  1982-05       Impact factor: 22.113

8.  Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension.

Authors:  H S Gilbert; V Praloran; E R Stanley
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

9.  Enhanced hematopoietic growth factor production in an experimental myeloproliferative syndrome.

Authors:  M C Le Bousse-Kerdilès; M Souyri; F Smadja-Joffe; V Praloran; C Jasmin; H J Ziltener
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

10.  Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.

Authors:  E Brogi; T Wu; A Namiki; J M Isner
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690
View more
  3 in total

Review 1.  Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review.

Authors:  J A Sivak-Callcott; J Rootman; S L Rasmussen; R A Nugent; V A White; D Paridaens; Z Currie; G Rose; B Clark; A A McNab; F V Buffam; J M Neigel; M Kazim
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.

Authors:  Xiaoli Wang; Sonam Prakash; Min Lu; Joseph Tripodi; Fei Ye; Vesna Najfeld; Yan Li; Myron Schwartz; Rona Weinberg; Paul Roda; Attilio Orazi; Ronald Hoffman
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

3.  Primary myelofibrosis and the "bad seeds in bad soil" concept.

Authors:  Marie-Caroline Le Bousse-Kerdilès
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.